...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Message: Comments on the AGM

"Question: will we know about the DATA over the weekend or will we have to wait till Monday morning meeting with DM before Markets open,...?"

Yes, we should know about the data presented at the AHA late breaker on Nov 16th same day, if not simultaneous with the presentation. Media will be covering all of the late breakers and there is a good chance that there will be a company announcement and possibly scientific BETonMACE publication same day. Once the AHA presentation is given, the AHA embargo is lifted and the floodgates of information should open.


New Message
Please login to post a reply